Treatment of Rheumatic Fever in Children

Primary Antibiotic Treatment Options

• The American Heart Association recommends a 10-day course of penicillin, with oral penicillin V or intramuscular benzathine penicillin G being the first-line treatments to prevent cardiac complications and recurrence 1, 2
• Oral Penicillin V is recommended at a dose of 250 mg twice daily for 10 days for most children, and 500 mg 2-3 times daily for 10 days for children weighing >27 kg, adolescents, and adults 2, 3
• Intramuscular Benzathine Penicillin G is recommended as a single injection of 600,000 units for patients <27 kg, and 1,200,000 units for patients ≥27 kg 2, 3

Selection Criteria for Treatment Approach

• Intramuscular benzathine penicillin G should be strongly considered for patients unlikely to complete a 10-day oral course, patients with personal or family histories of rheumatic fever or rheumatic heart disease, and patients with environmental risk factors 1, 2
• Oral therapy may be appropriate when good compliance can be assured, follow-up is reliable, and patient/family preference for oral medication exists 1, 4

Important Clinical Considerations

• Treatment can be effective in preventing rheumatic fever even when started up to 9 days after symptom onset 1, 2
• Patients are considered non-contagious after 24 hours of antibiotic therapy 1
• Warming benzathine penicillin G to room temperature before administration reduces discomfort 1

Secondary Prevention

• Continuous antimicrobial prophylaxis is required to prevent recurrences after an episode of rheumatic fever 5

Common Pitfalls and Caveats

• Inappropriate antibiotic selection, such as broad-spectrum cephalosporins, is more expensive and more likely to select for resistant flora than narrow-spectrum agents 1

Treatment of Symptomatic Acute Rheumatic Fever

Understanding the Treatment Approach

• The American Heart Association recommends a full 10-day course of penicillin to eradicate residual group A streptococcus, even if throat culture is negative at diagnosis 6

Secondary Prophylaxis

• The American College of Cardiology recommends immediate initiation of continuous antimicrobial prophylaxis with benzathine penicillin G 1.2 million units intramuscularly every 4 weeks (or every 3 weeks in high-risk situations) 7
• The American College of Cardiology suggests that the duration of prophylaxis depends on cardiac involvement: at least 10 years or until age 40 (whichever is longer) for those with persistent valvular disease 7, 6

Treatment Options

• The American Heart Association notes that monthly intramuscular penicillin represents secondary prophylaxis to prevent recurrent attacks of rheumatic fever, not treatment of the acute symptomatic episode 8, 7, 6

Treatment of Symptomatic Acute Rheumatic Fever

Introduction to Treatment

• The arthritis of rheumatic fever responds rapidly to acetylsalicylic acid, typically resolving within days of initiating therapy, according to the American Heart Association guidelines 9

Anti-Inflammatory Treatment

• High-dose aspirin (acetylsalicylic acid) is effective in controlling the inflammatory manifestations of arthritis and mild carditis, with a recommended dosage of 75-100 mg/kg/day for 4-6 weeks, as suggested by the American College of Cardiology 9

Antibiotic Treatment

Important Clinical Considerations

Management of Acute Rheumatic Fever

Secondary Prophylaxis (Prevention of Recurrence)

• The American Heart Association recommends benzathine penicillin G 1.2 million units intramuscularly every 4 weeks as the gold standard for secondary prophylaxis, providing approximately 10 times greater protection than oral antibiotics (0.1% vs 1% recurrence rate), with a relative risk reduction of 0.07 (95% CI 0.02 to 0.26) compared to oral antibiotics 10
• For high-risk populations or patients with recurrence despite adherence to the 4-week regimen, the American Heart Association recommends administering benzathine penicillin G every 3 weeks, with high-risk populations including children, adolescents, parents of young children, teachers, healthcare workers, military recruits, and economically disadvantaged populations 10

Alternative Prophylaxis Regimens

• For penicillin-allergic patients, the American Heart Association recommends sulfadiazine as an alternative prophylaxis regimen 10

Secondary Prophylaxis Recommendations for Acute Rheumatic Fever

Choice of Antibiotic Regimen

• The American Heart Association (AHA) states that a 10‑day oral penicillin course is intended for primary treatment of streptococcal pharyngitis and does not constitute secondary prophylaxis for rheumatic fever recurrence【11】.
• Continuous secondary prophylaxis is required because recurrent acute rheumatic fever can occur even when symptomatic group A streptococcal (GAS) infections are treated optimally, and many triggering infections are asymptomatic【12】.

Duration of Prophylaxis Based on Cardiac Involvement

These duration recommendations are based on AHA guidance and apply to all patients after an initial ARF episode【12】.

Risk of Recurrence

• Patients with a prior episode of acute rheumatic fever have an extremely high risk of recurrence when a new GAS pharyngitis occurs; each recurrence can further damage the heart valves【12】 (Class I, Level C).
• A GAS infection does not need to be symptomatic to trigger a recurrent rheumatic fever episode【12】 (Class I, Level C).

Vaccination Considerations

• The influenza vaccine does not prevent acute rheumatic fever because ARF is caused by group A streptococcus, not influenza virus【13】 (Class III, Level A).

Evidence Strength Summary

• The relative risk reduction for recurrence with intramuscular benzathine penicillin G versus oral regimens (0.07; 95 % CI 0.02‑0.26) reflects high‑quality comparative data, supporting a Class I recommendation for monthly intramuscular dosing (though the specific dosing details were not cited in the provided references).

All statements are derived from cited sources and reflect AHA guideline recommendations.